103.67
price up icon0.35%   0.395
 
loading

Finanzdaten der Exact Sciences Corp-Aktie (EXAS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.25%
878.38
850.74 811.09 706.78 708.65
Cost Of Revenue
1.59%
262.56
266.81 248.63 206.24 196.07
Gross Profit
5.46%
615.83
583.93 562.45 500.55 512.59
Operating Expenses
14.59%
698.42
609.47 564.60 596.56 551.99
Benefits Costs and Expenses
10.93%
963.46
868.50 811.14 807.78 746.08
Costs And Expenses
10.93%
963.46
868.50 811.14 807.78 751.16
Operating Income/Loss
223.33%
-82.59
-25.55 -2.148 -96.01 -39.40
Nonoperating Income/Loss
131.95%
-2.488
7.788 2.091 -4.981 1.975
Income/Loss From Continuing Operations Before Tax
379.15%
-85.08
-17.76 -0.057 -100.99 -37.43
Income Tax Expense/Benefit, Deferred
305.99%
-1.032
0.501 -0.006 -1.007 -0.398
Income Tax Expense/Benefit
52.53%
0.872
1.837 1.128 0.224 0.808
Income/Loss From Continuing Operations After Tax
338.68%
-85.95
-19.59 -1.185 -101.22 -38.24
Net Income/Loss
338.68%
-85.95
-19.59 -1.185 -101.22 -38.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.81%
0.353
189.26 188.90 186.81 184.79
Diluted Average Shares
99.81%
0.353
189.26 188.90 186.81 184.79
Basic Earnings Per Share
350.00%
-0.45
-0.10 -0.01 -0.54 -0.21
Diluted Earnings Per Share
350.00%
-0.45
-0.10 -0.01 -0.54 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$264.90
price up icon 0.76%
diagnostics_research DGX
$199.32
price down icon 0.64%
diagnostics_research MTD
$1,175.83
price up icon 0.74%
$188.84
price down icon 0.09%
diagnostics_research IQV
$164.81
price up icon 1.19%
diagnostics_research WAT
$286.06
price up icon 0.95%
Kapitalisierung:     |  Volumen (24h):